Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells

Kyungsoo Ha(Georgia Regents Medical Center), Kapil N. Bhalla(University of South Florida)
Oncotarget
June 30, 2014
Cited by 159


Related Papers